Abstract
Reductions in persistent Human Papillomavirus (HPV) infection and related diseases have been well-documented among vaccinated males. However, awareness remains low in high-risk subgroups such as men who have sex with men (MSM) in China. This multicenter cross-sectional study of 3,057 MSM across 10 Chinese cities found that only 20.6% had baseline awareness of HPV. Following a targeted educational intervention, vaccination acceptability rose to 97.8%. Despite high willingness, significant price sensitivity exists, with only 2.5% willing to pay more than 2000 RMB. These findings underscore the urgent need for tailored public health education and economic subsidies to improve HPV vaccine uptake in this population.
Introduction
While HPV is frequently associated with cervical cancer, it is also a primary driver of anal and penile cancers, as well as genital warts in men. MSM face a disproportionately high risk for these pathologies, particularly when co-infected with HIV. Although the quadrivalent HPV vaccine has been available for males globally since 2009, public health initiatives in China have historically prioritized females. This study addresses the critical knowledge gap regarding HPV awareness and vaccine acceptability among Chinese MSM.
Methods
The researchers conducted a multicenter cross-sectional study across 10 cities in mainland China, categorized by economic development (Developed, Medium, and Less Developed).
- Participants: 3,057 MSM were recruited via NGOs, social media, and peer referrals.
- Procedure: Participants completed a baseline questionnaire on demographics and HPV knowledge, followed by a "knowledge lecture" regarding HPV risks and vaccine benefits.
- Evaluation: A post-test measured changes in vaccination willingness and "willingness-to-pay" (WTP) using interval regression models to estimate economic thresholds.
Key Results
The Awareness Gap and Information Channels
Baseline awareness was remarkably low: only 20.6% of participants had heard of HPV, and a mere 4.8% were aware of the HPV vaccine. This contrasts sharply with Western cohorts where awareness often exceeds 70%. The study identified a clear preference for digital information delivery; while many currently receive information through various channels, the internet is the most desired source for future knowledge.
Acceptability and Economic Barriers
The educational intervention proved highly effective, with vaccination willingness jumping to 97.8% post-lecture. This suggests that the primary barrier to vaccination is a lack of information rather than inherent hesitancy. However, economic factors remain a significant hurdle. The study revealed a sharp decline in willingness as the price of the vaccine increased.
Key motivators for vaccination included general health consciousness (75.1%) and confidence in vaccine efficacy (44.1%). Conversely, the primary concerns were vaccine safety (54.2%) and the perceived severity of HPV infection (52.3%).
Discussion and Policy Implications
The study demonstrates that Chinese MSM are highly receptive to HPV vaccination once informed of its benefits. However, the current market price of the vaccine exceeds the WTP for the vast majority of this population. To achieve effective public health outcomes, the authors recommend:
- Enhanced Education: Utilizing internet-based platforms to deliver targeted health information to the MSM community.
- Economic Subsidies: Implementing government subsidies to align vaccine costs with the population's WTP (ideally below 500 RMB).
- Clinical Expansion: Accelerating clinical trials for males in China to facilitate formal approval and integration into national immunization programs.
While the study is limited by potential selection bias from NGO-based recruitment, it provides a robust foundation for future public health strategies targeting high-risk male populations in China.
Summary updated